Epidemiological characteristics of heart transplant recipients in Peru 2010-2020

Objective. To evaluate the epidemiological, clinical, surgical, pathological characteristics and outcomes in the follow-up of heart transplant recipients at the National Cardiovascular Institute during 2010-2020. Material and methods. A retrospective descriptive study was performed by reviewing the...

ver descrição completa

Detalhes bibliográficos
Autores: Polo Lecca, Gracia del Carmen, Soplopuco Palacios, Franz Ronald, Alarco León, Walter Alberto, Aguirre Zurita, Oscar Nelson, Aguilar Carranza, Cristian, Villarroel Villa, Ruth Eneida, Prado Gómez, Tommy Leonel, Tapia Leonardo, José Luis, Lescano Alva, Miguel Ángel, Robles Velarde, Víctor Justo, Morón Castro, Julio Alberto, Donayre Moquillaza, Yulma, Colque Rojas, Teresa, Palma Ortecho, Luis Javier, Gálvez Caballero, David Germán
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2021
País:Perú
Recursos:Instituto Nacional Cardiovascular
Repositorio:Archivos peruanos de cardiología y cirugía cardiovascular
Idioma:español
OAI Identifier:oai:apcyccv.org.pe:article/187
Acesso em linha:https://apcyccv.org.pe/index.php/apccc/article/view/187
Access Level:acceso abierto
Palavra-chave:Trasplante de corazón
Cardiopatías
Mortalidad
Sobrevida
Perú
Heart transplantation
Heart diseases
Mortality
Survival
Peru
Descrição
Resumo:Objective. To evaluate the epidemiological, clinical, surgical, pathological characteristics and outcomes in the follow-up of heart transplant recipients at the National Cardiovascular Institute during 2010-2020. Material and methods. A retrospective descriptive study was performed by reviewing the medical records of patients undergoing heart transplantation at a national referral center, describing the clinical, surgical, laboratory, pathology characteristics and survival of patients up to 10 years of follow-up. Results. Eightysix patients were transplanted in 10 years, the median age was 41 years (RIQ 28-56), being predominantly male (66.3%). The three leading causes of indication for heart transplantation were: dilated cardiomyopathy (48.9%), ischemic heart disease (17.4%), and myocarditis (6.9%). Total ischemia time was 160 minutes (RIQ 129.7-233.5). Survival at one, five, and ten years was 84.8%, 73.6%, and 65.7% respectively. The main cause of death was non-cardiac: infectious (39.1%) and of unknown origin (26%). Conclusions. The main etiology of heart failure in heart transplant recipients in Peru in recent years was nonischemic dilated cardiomyopathy. We observed that the survival rate was similar to that of international registries; however, the rate of mortality due to infectious causes and death of unknown origin is high, which poses a challenge in the management of post-transplant patients.

Registos relacionados